Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatmentâ:âConsiderations based on experience and a literature review.

Tashiro, Seiki; Tsuji, Tatsuya; Miyake, Hidenori; Kamo, Hitomi; Sumise, Yuko; Takai, Shigeharu; Yoshioka, Kazuo

Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatmentâ:âConsiderations based on experience and a literature review.

Tashiro, Seiki; Tsuji, Tatsuya; Miyake, Hidenori; Kamo, Hitomi; Sumise, Yuko; Takai, Shigeharu; Yoshioka, Kazuo.

Afiliação

Tashiro S; Taoka Hospital, Tokushima, Japan.
Tsuji T; The University of Tokushima (Professor Emeritus), Tokushima, Japan.
Miyake H; Hasuda Clinic, Kumamoto, Japan.
Kamo H; Tokushima Municipal Hospital, Tokushima, Japan.
Sumise Y; Taoka Hospital, Tokushima, Japan.
Takai S; Taoka Hospital, Tokushima, Japan.
Yoshioka K; Taoka Hospital, Tokushima, Japan.

J Med Invest ; 68(1.2): 15-21, 2021.

Article em En | MEDLINE | ID: mdl-33994461

Assuntos

Neoplasias dos Ductos Biliares; Carcinoma Hepatocelular; Colangiocarcinoma; Neoplasias Hepáticas; Neoplasias dos Ductos Biliares/cirurgia; Ductos Biliares Intra-Hepáticos/cirurgia; Colangiocarcinoma/cirurgia; Humanos; Prognóstico

Palavras-chave

hepatitis virus; hepatocellular carcinoma (HCC); intrahepatic cholangiocarcinoma (ICC); lenvatinib; nibolumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google